FDA 483 - Eric T. Rush M.D - October 24, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Eric T. Rush M.D. in Kansas City, MO, revealed significant deficiencies in the conduct of clinical trials. Observations included failure to follow investigational plans, such as missed study visits, unperformed study activities, delayed reporting of serious adverse events, and inadequate documentation of adverse events. Additionally, the firm experienced a lapse in IRB approval for a clinical study due to untimely submission of required documentation.
- Person
ID · a727092f-e804-4b8e-9adf-c5a5cf2b747a